AstraZeneca Joins Coronavirus Vaccine Race, Great For Biotech ETFs
May 21, 2020 at 14:42 PM EDT
With the race to find a vaccine for the coronavirus, now drugmaker AstraZeneca is the latest to receive funding to generate a panacea. AstraZeneca was awarded over $1 billion from the U.S. Health Department’s Biomedical Advanced Research and Development Authority to formulate a coronavirus vaccine...
